Testing effectiveness (Phase 2)Ended earlyNCT02539459What this trial is testingSporadic Angiomyolipomas (AMLs) Growth Kinetics While on EverolimusWho this might be right forSporadic Angiomyolipomas (AMLs) Fox Chase Cancer Center 20